首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
FDA approves first anti-TFPI antibody for haemophilia A and B
被引:0
|
作者
:
Mullard, Asher
论文数:
0
引用数:
0
h-index:
0
Mullard, Asher
机构
:
来源
:
NATURE REVIEWS DRUG DISCOVERY
|
2024年
/ 23卷
/ 12期
关键词
:
D O I
:
10.1038/d41573-024-00175-4
中图分类号
:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号
:
071005 ;
0836 ;
090102 ;
100705 ;
摘要
:
引用
收藏
页码:884 / 884
页数:1
相关论文
共 50 条
[21]
MG1113, a specific anti-TFPI antibody, rebalances the coagulation system and promotes hemostasis in hemophilia
Hwang, Sungho
论文数:
0
引用数:
0
h-index:
0
机构:
GC Pharma, Yongin, South Korea
GC Pharma, Yongin, South Korea
Hwang, Sungho
Hwang, Sung-ho
论文数:
0
引用数:
0
h-index:
0
机构:
Greencross, Yongin, South Korea
GC Pharma, Yongin, South Korea
Hwang, Sung-ho
Kwak, Heecheon
论文数:
0
引用数:
0
h-index:
0
机构:
GC Pharma, Yongin, South Korea
GC Pharma, Yongin, South Korea
Kwak, Heecheon
Lee, Sumin
论文数:
0
引用数:
0
h-index:
0
机构:
Mogam Inst Biomed Res, Yongin, South Korea
GC Pharma, Yongin, South Korea
Lee, Sumin
Kwon, YooungEun
论文数:
0
引用数:
0
h-index:
0
机构:
GC Pharma, Yongin, South Korea
GC Pharma, Yongin, South Korea
Kwon, YooungEun
Kang, Hyunju
论文数:
0
引用数:
0
h-index:
0
机构:
GC Pharma, Yongin, South Korea
GC Pharma, Yongin, South Korea
Kang, Hyunju
Choi, Gahee
论文数:
0
引用数:
0
h-index:
0
机构:
GC Pharma, Yongin, South Korea
GC Pharma, Yongin, South Korea
Choi, Gahee
Jo, Seunghyun
论文数:
0
引用数:
0
h-index:
0
机构:
GC Pharma, Yongin, South Korea
GC Pharma, Yongin, South Korea
Jo, Seunghyun
Jung, Myung Eun
论文数:
0
引用数:
0
h-index:
0
机构:
GC Pharma, Yongin, South Korea
GC Pharma, Yongin, South Korea
Jung, Myung Eun
Jo, Euicheol
论文数:
0
引用数:
0
h-index:
0
机构:
Mogam Inst Biomed Res, Yongin, South Korea
GC Pharma, Yongin, South Korea
Jo, Euicheol
HAEMOPHILIA,
2020,
26
: 42
-
42
[22]
FDA approves second anti-amyloid antibody for Alzheimer disease
Asher Mullard
论文数:
0
引用数:
0
h-index:
0
Asher Mullard
Nature Reviews Drug Discovery,
2023,
22
: 89
-
89
[23]
FDA approves third anti-amyloid antibody for Alzheimer disease
Mullard, Asher
论文数:
0
引用数:
0
h-index:
0
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY,
2024,
23
(08)
: 571
-
571
[24]
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal Antibody
Yuhong Xiang
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Yuhong Xiang
Chuenlei Parng
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Chuenlei Parng
Katrina Olson
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Katrina Olson
Elena Seletskaia
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Elena Seletskaia
Boris Gorovits
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Boris Gorovits
Darshana Jani
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Darshana Jani
Teresa Caiazzo
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Teresa Caiazzo
Alison Joyce
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Alison Joyce
Jean Donley
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc,
Jean Donley
The AAPS Journal,
21
[25]
Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration
Agerso, Henrik
论文数:
0
引用数:
0
h-index:
0
机构:
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Agerso, Henrik
Overgaard, Rune Viig
论文数:
0
引用数:
0
h-index:
0
机构:
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Overgaard, Rune Viig
Petersen, Mads Bjelke
论文数:
0
引用数:
0
h-index:
0
机构:
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Petersen, Mads Bjelke
Hansen, Lene
论文数:
0
引用数:
0
h-index:
0
机构:
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Hansen, Lene
Hermit, Mette Brunsgaard
论文数:
0
引用数:
0
h-index:
0
机构:
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Hermit, Mette Brunsgaard
Sorensen, Mette Hogh
论文数:
0
引用数:
0
h-index:
0
机构:
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Sorensen, Mette Hogh
Petersen, Lars Christian
论文数:
0
引用数:
0
h-index:
0
机构:
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Petersen, Lars Christian
Hilden, Ida
论文数:
0
引用数:
0
h-index:
0
机构:
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark
Hilden, Ida
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,
2014,
56
: 65
-
69
[26]
FDA approves second anti-amyloid antibody for Alzheimer disease
Mullard, Asher
论文数:
0
引用数:
0
h-index:
0
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY,
2023,
22
(02)
: 89
-
89
[27]
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal Antibody
Xiang, Yuhong
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Xiang, Yuhong
Parng, Chuenlei
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Parng, Chuenlei
Olson, Katrina
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Olson, Katrina
Seletskaia, Elena
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Seletskaia, Elena
Gorovits, Boris
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Gorovits, Boris
Jani, Darshana
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Jani, Darshana
Caiazzo, Teresa
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Caiazzo, Teresa
Joyce, Alison
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Joyce, Alison
Donley, Jean
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA 01810 USA
Pfizer Inc, Andover, MA 01810 USA
Donley, Jean
AAPS JOURNAL,
2019,
21
(03):
[28]
FDA APPROVES FIRST BIOSIMILAR
Erickson, Britt
论文数:
0
引用数:
0
h-index:
0
Erickson, Britt
CHEMICAL & ENGINEERING NEWS,
2015,
93
(11)
: 4
-
4
[29]
FDA approves first bispecific
Asher Mullard
论文数:
0
引用数:
0
h-index:
0
Asher Mullard
Nature Reviews Drug Discovery,
2015,
14
: 7
-
7
[30]
FDA approves first bispecific
不详
论文数:
0
引用数:
0
h-index:
0
不详
NATURE REVIEWS DRUG DISCOVERY,
2015,
14
(01)
: 7
-
7
←
1
2
3
4
5
→